ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE LA PROTEÍNA DE UNIÓN A LIPOPOLISACÁRIDOS (LBP).
Mexico·Clase I·III. Agentes de
diagnóstico·SIEMENS HEALTHCARE
DIAGNOSTICS, S. DE R.L. DE
C.V.·Registered June 20, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ADVIA CENTAUR® PROTEÍNA DE UNIÓN A LIPOPOLISACÁRIDOS (LIPOPOLYSACCHARIDE BINDING PROTEIN, LBP).
- Trade Name (English)
- ADVIA CENTAUR® PROTEÍNA DE UNIÓN A LIPOPOLISACÁRIDOS (LIPOPOLYSACCHARIDE BINDING PROTEIN, LBP).
- Analysis ID
- 1737R2024 SSA
- Registration Date
- June 20, 2024
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE LA PROTEÍNA DE UNIÓN A LIPOPOLISACÁRIDOS (LBP). (ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE LA PROTEÍNA DE UNIÓN A LIPOPOLISACÁRIDOS (LBP).) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1737R2024 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on June 20, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.